Home » Topics » Conferences

Conferences
RSS

New orthotopic xenograft breast cancer murine models developed

April 1, 2022

Novel humanized HIS-BRGS mouse model to evaluate immune-related kidney toxicities

April 1, 2022

BLU-945 for treatment-resistant EGFR T790M mutation-driven lung cancer

April 1, 2022

New cathepsin L inhibitors for the treatment of HCC

March 31, 2022

AC-0027136 improves memory impairment and mitochondrial function

March 31, 2022

ANDY mouse mimics age-dependent NAD decline and its metabolic impact

March 31, 2022

Adenosine A2B receptor targeting protects against acetaminophen-induced hepatotoxicity

March 31, 2022

Researchers present new Slc39a14-knockout dystonia murine model

March 30, 2022

AMG-650: a first-in-class KIF18A inhibitor for the treatment of chromosomally unstable cancers

March 30, 2022

Pimavanserin exerts anticancer effects via autophagy-mediated apoptosis

March 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...